{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:34:12Z","timestamp":1777419252075,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10103-021-03484-x","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T04:33:07Z","timestamp":1641443587000},"page":"2203-2208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM)"],"prefix":"10.1007","volume":"37","author":[{"given":"Kun-Ling","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Hsiang","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Xi","family":"Loo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Yin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Chien","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1102-0512","authenticated-orcid":false,"given":"Cheng-Yu","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"issue":"10","key":"3484_CR1","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","volume":"21","author":"DJ Portman","year":"2014","unstructured":"Portman DJ, Gass ML (2014) Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women\u2019s Sexual Health and the North American Menopause Society. Menopause 21(10):1063\u20131068","journal-title":"Menopause"},{"issue":"Suppl 1","key":"3484_CR2","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/j.maturitas.2005.06.014","volume":"52","author":"C Castelo-Branco","year":"2005","unstructured":"Castelo-Branco C, Cancelo MJ, Villero J, Nohales F, Juli\u00e1 MD (2005) Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas 52(Suppl 1):S46-52","journal-title":"Maturitas"},{"issue":"10","key":"3484_CR3","first-page":"3090","volume":"61","author":"GA Bachmann","year":"2000","unstructured":"Bachmann GA, Nevadunsky NS (2000) Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 61(10):3090\u20133096","journal-title":"Am Fam Physician"},{"issue":"4 Pt 2","key":"3484_CR4","first-page":"722","volume":"92","author":"L Cardozo","year":"1998","unstructured":"Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L (1998) Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 92(4 Pt 2):722\u2013727","journal-title":"Obstet Gynecol"},{"key":"3484_CR5","doi-asserted-by":"crossref","unstructured":"(2013) Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 20(9):888\u2013902; quiz 903\u2013884","DOI":"10.1097\/GME.0b013e3182a122c2"},{"issue":"6","key":"3484_CR6","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/AOG.0000000000000526","volume":"124","author":"DD Rahn","year":"2014","unstructured":"Rahn DD, Carberry C, Sanses TV, Mamik MM, Ward RM, Meriwether KV, Olivera CK, Abed H, Balk EM, Murphy M (2014) Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstet Gynecol 124(6):1147\u20131156","journal-title":"Obstet Gynecol"},{"key":"3484_CR7","unstructured":"FDA warns against use of energy-based devices to perform vaginal rejuvenation or vaginal cosmetic procedures: FDA safety communication. https:\/\/www.fda.gov\/medical-devices\/safety-communications\/fda-warns-against-use-energy-based-devices-perform-vaginal-rejuvenation-or-vaginal-cosmetic"},{"key":"3484_CR8","unstructured":"Fractional Laser Treatment of Vulvovaginal Atrophy and U.S. Food and Drug Administration Clearance.\u00a0https:\/\/www.acog.org\/clinical-information\/policy-and-position-statements\/position-statements\/2018\/fractional-laser-treatment-of-vulvovaginal-atrophy-and-us-food-and-drug-administration-clearance"},{"issue":"2","key":"3484_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/lsm.20080","volume":"35","author":"B Drnovsek-Olup","year":"2004","unstructured":"Drnovsek-Olup B, Beltram M, Pizem J (2004) Repetitive Er:YAG laser irradiation of human skin: a histological evaluation. Lasers Surg Med 35(2):146\u2013151","journal-title":"Lasers Surg Med"},{"issue":"10","key":"3484_CR10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/lsm.20380","volume":"38","author":"K Kunzi-Rapp","year":"2006","unstructured":"Kunzi-Rapp K, Dierickx CC, Cambier B, Drosner M (2006) Minimally invasive skin rejuvenation with Erbium: YAG laser used in thermal mode. Lasers Surg Med 38(10):899\u2013907","journal-title":"Lasers Surg Med"},{"issue":"6","key":"3484_CR11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1468-2494.2009.00567.x","volume":"32","author":"MO Bodendorf","year":"2010","unstructured":"Bodendorf MO, Willenberg A, Anderegg U, Grunewald S, Simon JC, Paasch U (2010) Connective tissue response to fractionated thermo-ablative erbium: YAG skin laser treatment. Int J Cosmet Sci 32(6):435\u2013445","journal-title":"Int J Cosmet Sci"},{"issue":"2","key":"3484_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/lsm.22569","volume":"49","author":"A Gaspar","year":"2017","unstructured":"Gaspar A, Brandi H, Gomez V, Luque D (2017) Efficacy of erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg Med 49(2):160\u2013168","journal-title":"Lasers Surg Med"},{"key":"3484_CR13","first-page":"38","volume":"1","author":"IS Ibinaeva","year":"2012","unstructured":"Ibinaeva IS, Apolikhina IA, Makhmedzhanova FN, Muslimova SZ (2012) ICIQ-SF questionnaire in women with urinary incontinence. Urologiia 1:38\u201342","journal-title":"Urologiia"},{"issue":"2","key":"3484_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/nau.1930140206","volume":"14","author":"JS Uebersax","year":"1995","unstructured":"Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA (1995) Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn 14(2):131\u2013139","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"3484_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.urology.2006.02.042","volume":"68","author":"Y Homma","year":"2006","unstructured":"Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, Yamanishi T, Yamaguchi O, Takeda M, Nishizawa O (2006) Symptom assessment tool for overactive bladder syndrome\u2013overactive bladder symptom score. Urology 68(2):318\u2013323","journal-title":"Urology"},{"issue":"1","key":"3484_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ajog.2004.12.025","volume":"193","author":"MD Barber","year":"2005","unstructured":"Barber MD, Walters MD, Bump RC (2005) Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol 193(1):103\u2013113","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"3484_CR17","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s00192-019-03991-0","volume":"30","author":"S Srisukho","year":"2019","unstructured":"Srisukho S, Pantasri T, Piyamongkol W, Phongnarisorn C, Morakote N (2019) The experience of genitourinary syndrome of menopause (GSM) among Thai postmenopausal women: the non-reporting issue. Int Urogynecol J 30(11):1843\u20131847","journal-title":"Int Urogynecol J"},{"issue":"1","key":"3484_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1210\/jcem-57-1-133","volume":"57","author":"FP Mandel","year":"1983","unstructured":"Mandel FP, Geola FL, Meldrum DR, Lu JH, Eggena P, Sambhi MP, Hershman JM, Judd HL (1983) Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab 57(1):133\u2013139","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3484_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0889-8545(21)00629-X","volume":"21","author":"VL Baker","year":"1994","unstructured":"Baker VL (1994) Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery. Obstet Gynecol Clin North Am 21(2):271\u2013297","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"11","key":"3484_CR20","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJM199309093291102","volume":"329","author":"R Raz","year":"1993","unstructured":"Raz R, Stamm WE (1993) A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 329(11):753\u2013756","journal-title":"N Engl J Med"},{"issue":"2","key":"3484_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/13697137.2018.1436538","volume":"21","author":"M Gambacciani","year":"2018","unstructured":"Gambacciani M, Levancini M, Russo E, Vacca L, Simoncini T, Cervigni M (2018) Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Climacteric 21(2):148\u2013152","journal-title":"Climacteric"},{"issue":"4 Suppl 1","key":"3484_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0090-4295(03)00676-9","volume":"62","author":"D Robinson","year":"2003","unstructured":"Robinson D, Cardozo LD (2003) The role of estrogens in female lower urinary tract dysfunction. Urology 62(4 Suppl 1):45\u201351","journal-title":"Urology"},{"issue":"1","key":"3484_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3889\/oamjms.2018.058","volume":"6","author":"S Salvatore","year":"2018","unstructured":"Salvatore S, Fran\u00e7a K, Lotti T, Parma M, Palmieri S, Candiani M, D\u2019Este E, Viglio S, Cornaglia AI, Farina A et al (2018) Early Regenerative modifications of human postmenopausal atrophic vaginal mucosa following fractional CO(2) laser treatment. Open Access Maced J Med Sci 6(1):6\u201314","journal-title":"Open Access Maced J Med Sci"},{"issue":"1","key":"3484_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/GME.0000000000000955","volume":"25","author":"VL Cruz","year":"2018","unstructured":"Cruz VL, Steiner ML, Pompei LM, Strufaldi R, Fonseca FLA, Santiago LHS, Wajsfeld T, Fernandes CE (2018) Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Menopause 25(1):21\u201328","journal-title":"Menopause"},{"key":"3484_CR25","first-page":"7915813","volume":"2019","author":"KL Lin","year":"2019","unstructured":"Lin KL, Chou SH, Long CY (2019) Effect of Er:YAG laser for women with stress urinary incontinence. Biomed Res Int 2019:7915813","journal-title":"Biomed Res Int"},{"issue":"3","key":"3484_CR26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/gme.0b013e3181948dd0","volume":"16","author":"NE Avis","year":"2009","unstructured":"Avis NE, Brockwell S, Randolph JF Jr, Shen S, Cain VS, Ory M, Greendale GA (2009) Longitudinal changes in sexual functioning as women transition through menopause: results from the Study of Women\u2019s Health Across the Nation. Menopause 16(3):442\u2013452","journal-title":"Menopause"},{"issue":"7","key":"3484_CR27","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1111\/jsm.12190","volume":"10","author":"SA Kingsberg","year":"2013","unstructured":"Kingsberg SA, Wysocki S, Magnus L, Krychman ML (2013) Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women\u2019s VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. J Sex Med 10(7):1790\u20131799","journal-title":"J Sex Med"},{"issue":"6","key":"3484_CR28","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/S0002-9378(97)70345-4","volume":"176","author":"JC Caillouette","year":"1997","unstructured":"Caillouette JC, Sharp CF Jr, Zimmerman GJ, Roy S (1997) Vaginal pH as a marker for bacterial pathogens and menopausal status. Am J Obstet Gynecol 176(6):1270\u20131275 (discussion 1275-1277)","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"3484_CR29","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.ajog.2003.12.015","volume":"190","author":"S Roy","year":"2004","unstructured":"Roy S, Caillouette JC, Roy T, Faden JS (2004) Vaginal pH is similar to follicle-stimulating hormone for menopause diagnosis. Am J Obstet Gynecol 190(5):1272\u20131277","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"3484_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.esxm.2020.01.001","volume":"8","author":"M Mitsuyuki","year":"2020","unstructured":"Mitsuyuki M, \u0160tok U, Hreljac I, Yoda K, Vi\u017eintin Z (2020) Treating vaginal laxity using nonablative Er:YAG laser: a retrospective case series of patients from 2.5 years of clinical practice. Sex Med 8(2):265\u2013273","journal-title":"Sex Med"},{"issue":"4","key":"3484_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/GME.0000000000001293","volume":"26","author":"C Gordon","year":"2019","unstructured":"Gordon C, Gonzales S, Krychman ML (2019) Rethinking the techno vagina: a case series of patient complications following vaginal laser treatment for atrophy. Menopause 26(4):423\u2013427","journal-title":"Menopause"},{"issue":"sup1","key":"3484_CR32","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1080\/13697137.2020.1813098","volume":"23","author":"M Gambacciani","year":"2020","unstructured":"Gambacciani M, Cervigni M, Gaspar A, NovakovMiki\u0107 A, Gaviria J, Koron N, Vizintin Z (2020) Safety of vaginal erbium laser: a review of 113,000 patients treated in the past 8 years. Climacteric 23(sup1):S28-s32","journal-title":"Climacteric"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-021-03484-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-021-03484-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-021-03484-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T07:09:07Z","timestamp":1653721747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-021-03484-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3484"],"URL":"https:\/\/doi.org\/10.1007\/s10103-021-03484-x","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"assertion":[{"value":"19 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}